{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-26-000050","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2026-08-03T20:07:39+00:00","discovered_at":"2026-08-03T20:09:00.394852+00:00","generated_at":"2026-08-03T20:09:20.063765+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Keros Therapeutics files updated corporate presentation; no specific material facts disclosed","bullets":["The filing contains no specific new material information beyond a routine corporate presentation update.","The presentation is used for meetings with investors, analysts, and others.","No financial results, clinical data, or guidance changes were disclosed in the filing.","The exhibit text provided is truncated and does not contain complete details."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-26-000050","json":"https://secwatch.observer/filing/0001664710-26-000050.json","markdown":"https://secwatch.observer/filing/0001664710-26-000050.md","text":"https://secwatch.observer/filing/0001664710-26-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000050/0001664710-26-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000050/kros-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:09:20.063765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}